1-3 of 3
Xuehua Ke, M.A.
Close
Sort by
Journal Articles

Chronic Myelomonocytic Leukemia Is Associated with More Frequent and More Rapid Progression to Acute Myeloid Leukemia and Shorter Survival Than Myelodysplastic Syndrome, but Is Less Frequently Treated: Analysis of Surveillance Epidemiology and End Results Data Linked to Medicare Enrollment Claims

Dan Zandberg, MD, Ting-Ying Huang, BSPharm, Xuehua Ke, M.A., Maria R. Baer, MD, Steven D. Gore, MD, Sheila Weiss Smith, PhD, FISPE, Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 2784.
https://doi.org/10.1182/blood.V118.21.2784.2784
Published: 2011
Journal Articles

Do Erythropoiesis-Stimulating Agents (ESAs) Affect Survival in Anemic Patients with Myelodysplastic Syndromes (MDS)?

Amy J. Davidoff, M.S., Ph.D., Xuehua Ke, M.A., Maria R. Baer, MD, Sheila R Weiss Smith, PhD, Dan Zandberg, MD, Franklin Hendrick, B.S., Masayo Sato, M.S., Peter L. Greenberg, MD, Steven D. Gore, MD
Journal: Blood
Blood (2011) 118 (21): 2794.
https://doi.org/10.1182/blood.V118.21.2794.2794
Published: 2011
Journal Articles

Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).

Amy J. Davidoff, PhD, M.S., Sheila Weiss Smith, PhD, Maria R Baer, M.D., Xuehua Ke, M.A., Jason M Bierenbaum, M.D., Franklin Hendrick, B.S., Diane L. McNally, BSPharm, M.S., Steven D. Gore, M.D.
Journal: Blood
Blood (2010) 116 (21): 3815.
https://doi.org/10.1182/blood.V116.21.3815.3815
Published: 2010